SAT0193 Early Discontinuation of First Line Biological Treatment With Etanercept in Patients With Rheumatoid Arthritis: Results From the Italian Gisea Registry
doi 10.1136/annrheumdis-2018-eular.3642
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism